Anagenics Limited announced that, subject to finalisation of customary onboarding requirements, Karen Matthews will be joining the Board as a Non-Executive Director. Karen is a business transformation advisor with over 25 years' experience leading business turnaround, change and strategies for business growth. Karen brings dynamic experience from the Beauty & Retail industry working for some of Australia's most iconic retail businesses including Ella Bache, Freedom Furniture and Myer and being recognised with industry awards.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.008 AUD | 0.00% | 0.00% | -57.89% |
May. 24 | Anagenics Signs Midkine Antibody Licencing Deal with Roquefort Therapeutics | MT |
Mar. 08 | Anagenics Appoints CEO | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-57.89% | 2.51M | |
+13.70% | 393B | |
+17.26% | 144B | |
+23.03% | 80.46B | |
-1.70% | 73.78B | |
-29.33% | 37.06B | |
-14.82% | 35.12B | |
+2.10% | 33.63B | |
+12.56% | 18.76B | |
+13.42% | 13.37B |
- Stock Market
- Equities
- AN1 Stock
- News Anagenics Limited
- Anagenics Limited Appoints Karen Matthews as Non-Executive Director